Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-024396
Filing Date
2022-06-28
Accepted
2022-06-28 16:27:06
Documents
1
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4034
  Complete submission text file 0000899243-22-024396.txt   5546
Mailing Address C/O INCYTE CORPORATION, EXPERIMENTAL STN ROUTE 141 & HENRY CLAY ROAD, BLDG. E336 WILMINGTON DE 19880
Business Address
Huber Reid M (Reporting) CIK: 0001607052 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39485 | Film No.: 221050457

Mailing Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142
Business Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142 (857) 320-4900
Tango Therapeutics, Inc. (Issuer) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations